Jack W. Leach v. E.I. du Pont de Nemours & Company (2005)

On 30 August 2001, approximately 80,000 people living in West Virginia and Ohio states filed a class-action lawsuit, alleging that DuPont’s Washington Works Plant in Washington, West Virginia, had contaminated the local water supplies with perfluorooctanoic acid, or PFOA, in Jack W. Leach, et al. v. E.I. du Pont de Nemours & Company (2005), hereafter Leach v. du Pont. PFOA is a human-made chemical, part of the PFAS family, more commonly called forever chemicals. PFOA plays a fundamental role in the production of materials like Teflon and nonstick and stain-resistant consumer products. The plaintiffs of the case alleged that DuPont failed to contain or warn the residents about the dangers of PFOA, which can include hormone disruptions, cancers, and pregnancy complications. The case led to a settlement in 2005 in which DuPont agreed to pay 70 million US dollars in class benefits, and also prompted changes in policy designed to protect individuals and communities from the dangers of PFOA and other forever chemicals.

1. PFAS and PFOA
2. Historical Background to the Case
3. How the Case Took Shape
4. Legal Proceedings and Settlement
5. Impact on Public Health and Environmental Law

PFAS and PFOA

PFAS, or per- and polyfluoroalkyl substances, form a class of human-made chemicals incorporated into a wide range of products due to their resistance to heat, water, and oil. Such properties make PFAS useful in nonstick cookware, waterproof fabrics, firefighting foams, and food packaging. At the same time, those properties also cause PFAS to remain in the environment for extended periods. Environmental scientists and regulatory agencies refer to PFAS as forever chemicals because they do not break down easily in nature or the human body.

One type of PFAS, perfluorooctanoic acid, or PFOA, is common in the production of nonstick coatings, stain-resistant materials, and other consumer goods. PFOA, like other PFAS, resists natural degradation and accumulates in water sources, soil, and the food chain. Once the chemicals enter the natural environment, people become exposed to them through drinking water, food packaging, household dust, and personal care products such as cosmetics and dental floss.

Historical Background to the Case

The Leach v. du Pont case centers on the long-term environmental and health consequences of PFOA contamination, specifically regarding public water supplies, and what its manufacturers knew about that risk as they were developing the materials. Researchers at the company 3M, based in Maplewood, Minnesota, began studying PFOA in 1947 as part of a new class of chemicals exhibiting uncommon resistance to heat, water, oil, and degradation. Shortly after the invention of PFOA, DuPont, headquartered in Wilmington, Delaware, became the primary company in developing PFOA’s potential. In 1944, DuPont registered the trademark for the related compound polytetrafluoroethylene, or PTFE, under the brand name Teflon, a new nonstick material. DuPont used PFOA in the production of PTFE and Teflon. The company originally developed PTFE for use in refrigerants, liquids used for cooling in air conditioning and refrigeration units. However, DuPont’s first industrial use of PTFE came during World War II for the Manhattan Project, a top-secret US military and government program that produced the atomic bomb. The program required passing the radioactive and corrosive chemical compound uranium hexafluoride through great quantities of pipes. Applying PTFE gaskets and valve seals to the piping prevented the critical material from leaking. By 1969, PTFE became stable enough for use in textiles with expanded PTFE, or ePTFE, membranes, resulting in Gore-Tex, a waterproof and breathable material that became common in raincoats and hiking boots.

Scientists at DuPont’s Kearny, New Jersey, site conducted early experiments with PTFE and faced chemical-related accidents, including fatalities due to explosions. By 1951, DuPont established a large-scale Teflon production facility in Parkersburg, West Virginia. That same year, the company began purchasing APFO, or ammonium perfluorooctanoate, from 3M. APFO is the chemical compound formed when an acidic proton on PFOA is replaced with an ammonium ion; APFO, then, is essentially the ammonium salt version of the PFOA solution. After the purchase, DuPont began incorporating PFOA as a processing aid for Teflon, referring to the chemical as C8 in internal documents due to the eight carbon atoms in its molecular structure, C₈HF₁₅O₂.

As forever chemicals became widely used in waterproof fabrics, cookware, and industrial applications, evidence mounted of their effects on environmental safety and health. Their ability to create highly resistant surfaces proved useful for many industries, ranging from automotive to architectural. However, that exceptional resistance posed unforeseen challenges. PFOA’s chemical stability means it does not easily degrade in the environment or in living organisms, persisting indefinitely and raising significant ecological and health concerns. By the 1990s, more scientific evidence and internal DuPont documents revealed the potential dangers of PFOA. The data showed that PFOA accumulated in human blood, transferred to developing embryos and fetuses, and posed significant risks to fetal development. Despite that knowledge, DuPont continued using and improperly disposing of PFOA, leading to widespread environmental contamination and serious health concerns that eventually formed the basis of the Leach v. Du Pont lawsuit.

How the Case Took Shape

Wilbur Tennant, a cattle farmer from Parkersburg, West Virginia, initiated a precursor to the Leach v. du Pont case when he noticed his cows dying under mysterious circumstances in the 1990s. Tennant observed that his cattle exhibited strange behaviors and physical deformities, which appeared after exposure to water sources near DuPont’s Washington Works plant. DuPont had purchased land from Tennant’s family to use as a landfill for its industrial waste, including PFOA. Tennant faced resistance from local lawyers, officials, and veterinarians when seeking help concerning his situation, as DuPont had significant economic influence in the region. After exhausting other options, Tennant turned to attorney Robert Bilott, a corporate defense lawyer at Taft Stettinius & Hollister, with headquarters in Cincinnati, Ohio, whose grandmother had ties to the Parkersburg area. Bilott agreed to take the case almost immediately after reviewing Tennant’s evidence. His background in environmental compliance cases gave him the tools to uncover strong evidence in favor of the case. The legal discovery process that Bilott engaged in showed that DuPont had knowingly discharged PFOA into unlined landfills and waterways, contaminating the water supply of surrounding communities and formed the basis of a private settlement in Tennant’s case. Bilott also filed a class-action lawsuit in 2001 on behalf of 80,000 people exposed to PFOA, culminating in the case Leach v. du Pont. The court case bears the surname of Jack W. Leach, one of the first plaintiffs in the case. Though not the first to raise concerns about DuPont’s role in PFOA exposure, Leach’s role as a named plaintiff helped formally represent the broader group of affected residents.

Legal Proceedings and Settlement

The plaintiffs filed Leach v. du Pont on 30 August 2001 in Kanawha County, West Virginia, before DuPont’s lawyers were granted a motion to change venue to the Circuit Court of Wood County, West Virginia. The hearings relied on extensive documentation, deposition and scientific data that both sides introduced. The plaintiffs’ attorneys presented internal DuPont documents showing that the company researchers had monitored PFOA levels in workers’ blood since the 1970s and had conducted animal studies indicating potential toxicity. Case filings and records from the US Environmental Protection Agency, or EPA, document human data from 1981 that show transfer of PFOA from those who are pregnant to their children before birth. Other internal records also show results from testing water samples in West Virginia and Ohio above DuPont’s guideline of one part per billion. At that time no national drinking water standard existed for PFOA.

During the final settlement hearing on 28 February 2005, the plaintiffs attested to reviewing over 1.5 million pages of corporate records and conducting thirty-five depositions. They also consulted experts in toxicology, which is the study of harmful effects on living organisms, epidemiology, which is the study of causes of disease in a population, and environmental science. The court proceedings focused on whether PFOA exposure created a significant public health risk and whether DuPont had withheld critical information that could have led to earlier regulatory action. The plaintiffs also introduced environmental sampling data, which identified PFOA contamination in the drinking water of six public districts, where levels exceeded DuPont’s internal safety guidelines.

DuPont’s legal team questioned whether PFOA exposure directly caused the reported health conditions. They referred to the absence of federal drinking water standards for PFOA at the time and cited studies that had not conclusively linked the chemical to human disease. They also proposed alternative exposure pathways, arguing that residents might have encountered similar chemicals from other sources. In court, DuPont’s attorneys cross-examined the plaintiffs’ experts, challenging the methodology of their studies and the statistical significance of their findings. DuPont also emphasized its compliance with existing regulations, stating that the company had disclosed information to government agencies and had voluntarily reduced emissions before litigation began.

In November 2004, Judge George W. Hill certified the class settlement, providing treatment to clean PFOA in the water supply for six public water districts: Lubeck Public Service District and Mason County Public Service District in West Virginia, and Belpre, Little Hocking, Tuppers Plains, and Pomeroy in Ohio. DuPont also agreed to pay 70 million dollars to the C8 Health Project, a yearlong data-gathering phase conducted by the independent company Brookmar, Inc. As part of the agreement, DuPont also committed to funding the C8 Science Panel, a group of three independent epidemiologists chosen jointly by the parties to the settlement, who examined whether exposure to PFOA contributed to specific diseases. The three epidemiologists were Tony Fletcher, researcher and lecturer of social and environmental health at the London School of Hygiene & Tropical Medicine in London, UK, David Savitz, professor of community health, obstetrics, and gynecology at Brown University in Providence, Rhode Island, and Kyle Steenland, professor of environmental and occupational health at Emory University in Atlanta, Georgia. The panel studied records and blood samples gathered by the C8 Health Project from approximately 69,000 people living in areas with contaminated water supplies as well as additional data. The settlement also delayed personal-injury lawsuits until the C8 Science Panel completed its research. Such a condition ensured that future legal claims relied on scientific data rather than assumptions about health risks.

Between 2011 and 2012, the panel released a series of reports identifying six diseases with a probable link to PFOA exposure. Their findings showed correlations between higher PFOA levels and higher rates of developing kidney cancer, testicular cancer, and ulcerative colitis, which is a chronic inflammation in the digestive tract that can cause abdominal pain and long-term health complications. The panel determined that irregular thyroid hormone levels correlated with PFOA exposure, affecting metabolism, energy regulation, and body temperature. Pregnant individuals with higher PFOA exposure experienced pregnancy-induced hypertension, which is an elevated blood pressure during pregnancy that increases risks for complications such as preeclampsia. Blood tests also showed that many individuals with significant PFOA exposure had hypercholesterolemia, which is increased cholesterol levels, capable of contributing to heart disease over time. Such findings established a strong link between PFOA and long-term health risks, creating a foundation for future legal claims.

After the panel published its results, plaintiffs filed more than 3,500 lawsuits against DuPont, arguing that the company’s handling of PFOA contamination had caused serious health problems. To manage the large number of cases, the parties agreed to combine them into a single legal proceeding called multidistrict litigation, or MDL. The process, used in complex lawsuits with hundreds or even thousands of litigants filing similar claims often stemming from a similar issue or cause, allowed one federal court to oversee pretrial proceedings and key legal decisions. The US District Court for the Southern District of Ohio took control of the litigation, with Chief Judge Edmund A. Sargus, Jr. presiding over the case.

Attorneys for each side used a trial strategy involving bellwether cases to determine how juries might respond to the evidence. A bellwether case is a test case selected from a larger group to help predict outcomes in similar cases. DuPont selected the case of Carla Marie Bartlett to serve as a bellwether case. In October 2015, the jury in Bartlett v. E. I. du Pont de Nemours & Company (2015) awarded 1.6 million dollars to Bartlett, a fifty-nine-year-old woman diagnosed with kidney cancer after PFOA exposure. As other bellwether cases progressed with similar jury decisions, DuPont and Chemours, a chemical company that in 2015 spun off from DuPont, agreed to settle the remaining lawsuits for 670.7 million dollars in February 2017, bringing the litigation to a close.

Impact on Public Health and Environmental Law

Leach v. du Pont exposed various gaps in the Toxic Substances Control Act, or TSCA, which is a law that the US Congress passed in 1976 to regulate industrial chemicals in the US. TSCA required companies to notify the EPA before producing or importing new chemicals, for companies to develop data on the health and environmental effects of their chemicals, and for companies to restrict or label chemicals that posed significant risks. But, in practice, those requirements meant that companies were essentially self-policing. As a result, substances such as PFOA remained in commercial production for decades without restrictions. The litigation demonstrated how regulatory policies allowed widespread exposure to chemicals not yet evaluated for effects on health. The case also contributed to the passage of the Frank R. Lautenberg Chemical Safety for the 21st Century Act in 2016, which amended TSCA by requiring the EPA to evaluate existing chemicals for potential risks.

Leach v. du Pont and the related personal-injury lawsuits also resulted in international actions, as well as broader public discourse and more research on forever chemicals. Regulatory agencies outside the US responded to concerns about PFAS chemicals, with governments in Europe, Australia, and Asia moving to limit or ban PFAS production and use. In the United States, on 10 April 2024, the EPA introduced enforceable limits for PFAS in drinking water and launched programs to address contamination in affected areas.

Documentaries like The Devil We Know in 2018, directed by Stephanie Soechtig, and the feature film Dark Waters in 2019, directed by Todd Haynes, brought wide attention to the Leach v. du Pont case. Those media adaptations highlighted the long-term health effects of PFAS exposure and the need for stronger corporate accountability. Additionally, the findings have inspired further scientific research on PFAS toxicity, including reproductive and developmental health risks.

The findings of the Leach v. du Pont C8 Science Panel not only validated the plaintiffs’ claims but also provided a basis for subsequent litigation. The case demonstrated how attorneys and experts deploy scientific evidence in complex litigation, such as the role of epidemiological studies in proving causation in civil cases involving toxic chemicals. The precedent set by the case remains valid in its jurisdiction, and the findings from the C8 Science Panel continued to be used in lawsuits involving PFAS contamination. For example, litigation targeting other major chemical manufacturers like 3M and Chemours has cited Leach v. du Pont as a benchmark for addressing corporate responsibility for harmful health effects.

Leach v. du Pont served as a model case in environmental law demonstrating a complex intersection between corporate accountability, scientific evidence, and public-health advocacy. By forcing DuPont to address its role in PFOA contamination, the case provided relief for affected communities and inspired a broader wave of regulatory and legal reform to protect against pollution from forever chemicals.

Sources

1. “2004 Complaints and 2005 Prehearing Exchange for E.I. DuPont de Nemours and Company.” United States Environmental Protection Agency, 2024. https://www.epa.gov/enforcement/2004-complaints-and-2005-prehearing-exchange-ei-dupont-de-nemours-and-company (Accessed October 18, 2025).
2. Bilott, Robert and Tom Schroder. Exposure: Poisoned Water, Corporate Greed, and One Lawyer’s Twenty-Year Battle Against DuPont. New York: Atria Books, 2019.
3. Boden, Samuel. “Presumptive Innocence v. the Precautionary principle: The Story of PFAS Regulation in the United States.” Environs: Environmental Law and Policy Journal, 44 (2020): 37–62. https://environs.law.ucdavis.edu/archives/44/1/presumptive-innocence-v-precautionary-principle-story-pfas-regulation-united-states (Accessed October 15, 2025).
4. “C-8 Class Action Settlement Documents.” Hill, Peterson, Carper, Bee & Deitzler, PLLC. https://www.hpcbd.com/personal-injury/dupont-c8/class-action-settlement-documents/ (Accessed October 15, 2025).
5. Dinis-Oliveira, Ricardo Jorge. “A Tribute to Robert Bilott and One of the Major Toxicological Discoveries: ‘Dark Waters’ and the poison truth behind the Teflon nightmare.” Scientific Letters, 1 (2024): 1–2. https://publicacoes.cespu.pt/index.php/sl/article/view/186 (Accessed October 15, 2025).
6. EPA Press Office. “Biden-Harris Administration Finalizes First-Ever National Drinking Water Standard to Protect 100M People from PFAS Pollution.” United States Environmental Protection Agency, 2024. https://www.epa.gov/newsreleases/biden-harris-administration-finalizes-first-ever-national-drinking-water-standard (Accessed October 8, 2025).
7. Fletcher, Tony, David Savitz, and Kyle Steenland. “The Science Panel Website.” C8 Science Panel. http://www.c8sciencepanel.org/index.html (Accessed October 18, 2025).
8. Frisbee, Stephanie J., A. Paul Brooks Jr, Arthur Maher, Patsy Flensborg, Susan Arnold, Tony Fletcher, Kyle Steenland, Anoop Shankar, Sarah S. Knox, Cecil Pollard, Joel A. Halverson, Verónica M. Vieira, Chuanfang Jin, Kevin M. Leyden, and Alan M. Ducatman. “The C8 Health Project: Design, Methods, and Participants.” Environmental Health Perspectives, 117 (2009): 1873–1882. https://ehp.niehs.nih.gov/doi/10.1289/ehp.0800379 (Accessed October 15, 2025).
9. Gaber, Nadia, Lisa Bero, and Tracy J. Woodruff. 2023. “The Devil They Knew: Chemical Documents Analysis of Industry Influence on PFAS Science.” Annals of Global Health, 89 (2023): 1–17. https://annalsofglobalhealth.org/articles/10.5334/aogh.4013 (Accessed October 15, 2025).
10. McDonald, Frederick A. “Omnipresent Chemicals: TSCA Preemption in the Wake of PFAS Contamination.” Pace Environmental Law Review, 37 (2019): 139–175. https://digitalcommons.pace.edu/pelr/vol37/iss1/4/ (Accessed October 15, 2025).
11. Molinek, Rudy. “The Long, Strange History of Teflon, the Indestructible Product Nothing Seems to Stick to.” Smithsonian Magazine. August 20, 2024. https://www.smithsonianmag.com/science-nature/the-long-strange-history-of-teflon-the-indestructible-product-nothing-seems-to-stick-to-180984920/ (Accessed October 15, 2025).
12. Nair, Arathy S. “DuPont settles lawsuits over leak of chemical used to make Teflon.” Reuters, February 13, 2017. https://www.reuters.com/article/business/dupont-settles-lawsuits-over-leak-of-chemical-used-to-make-teflon-idUSKBN15S18T/ (Accessed October 8, 2025).
13. “Our Current Understanding of the Human Health and Environmental Risks of PFAS.” United States Environmental Protection Agency, 2024. https://www.epa.gov/pfas/our-current-understanding-human-health-and-environmental-risks-pfas (Accessed October 5, 2025).
14. Paustenbach, Dennis J., Julie M. Panko, Paul K. Scott, and Kenneth M. Unice. “A Methodology for Estimating Human Exposure to Perfluorooctanoic Acid (PFOA): A Retrospective Exposure Assessment of a Community (1951–2003).” Journal of Toxicology and Environmental Health, Part A, 70 (2007): 28–57.
15. Rich, Nathaniel. “The Lawyer Who Became DuPont’s Worst Nightmare.” The New York Times, January 6, 2016. https://www.nytimes.com/2016/01/10/magazine/the-lawyer-who-became-DuPonts-worst-nightmare.html (Accessed October 4, 2025).
16. Samora, Sara. “The History of PFAS: From World War II to Your Teflon Pan.” Manufacturing Dive. December 6, 2023. https://www.manufacturingdive.com/news/the-history-behind-forever-chemicals-pfas-3m-dupont-pfte-pfoa-pfos/698254/ (Accessed October 3, 2025).
17. Steenland, Kyle, Tony Fletcher, Cheryl R. Stein, Scott M. Bartell, Lyndsey Darrow, Maria-Jose Lopez-Espinosa, P. Barry Ryan, David A. Savitz. “Review: Evolution of evidence on PFOA and health following the assessments of the C8 Science Panel.” Environment International, 145 (2020): 1–12. https://www.sciencedirect.com/science/article/pii/S0160412020320808 (Accessed October 4, 2025).
18. Steenland, Kyle, Tony Fletcher, and David A. Savitz. “Epidemiologic Evidence on the Health Effects of Perfluorooctanoic Acid (PFOA).” Environmental Health Perspectives, 118 (2010): 1100–1108. https://ehp.niehs.nih.gov/doi/10.1289/ehp.0901827 (Accessed October 3, 2025).
19. Thomas, Tiffany, Adel Malek, Jude Arokianathar, Elie Haddad, and Joanna Matthew. “Global Regulations Around PFAS: The Past, the Present and the Future.” International Chemical Regulatory and Law Review, 6 (2023): 3–17. https://icrl.lexxion.eu/article/icrl/2023/1/4/display/html (Accessed October 8, 2025).
20. Williams, Rose Marie. “Teflon Makes Life Easy, But Is It Safe?” Townsend Letter: The Examiner of Alternative Medicine, 275 (2006): 36–38. https://scholar.google.com/citations?view_op=view_citation&hl=en&user=jGHk7I4AAAAJ&citation_for_view=jGHk7I4AAAAJ:WF5omc3nYNoC (Accessed October 3, 2025).
21. Young, Elizabeth V. “Outsourcing the Jury: Barlett v. DuPont and the Role of Alternative Adjudication in Preserving Jury Fairness in Complex Scientific Litigation.” Ohio State Law Journal Sixth Circuit Review, 77 (2016): 15–30. https://heinonline.org/HOL/Page?collection=journals&handle=hein.journals/osljsxcr77&id=7&men_tab=srchresults (Accessed October 15, 2025).
22. Zirui Liu, Xintong Li, Shang Shi. “An Ethical Analysis Model to DuPont’s PFOA Event Based on Consequentialism Perspective.” In Proceedings of the 2021 International Conference on Enterprise Management and Economic Development (ICEMED 2021), eds. I. A. Majid, Z. J. Yang, J. Ren, J. A. Chen, and D. Hu, 143–149. Dordrecht: Atlantis Press, 2021. https://www.atlantis-press.com/proceedings/icemed-21/125957366 (Accessed October 15, 2025).